These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis. Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E. J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069 [Abstract] [Full Text] [Related]
3. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E. J Med Genet; 1993 Sep; 30(9):728-36. PubMed ID: 8411067 [Abstract] [Full Text] [Related]
11. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Bushby KM, Appleton R, Anderson LV, Welch JL, Kelly P, Gardner-Medwin D. Dev Med Child Neurol; 1995 Mar; 37(3):260-9. PubMed ID: 7890131 [Abstract] [Full Text] [Related]
17. [Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy]. Takeshima Y, Matsuo M. Nihon Rinsho; 1997 Dec; 55(12):3120-5. PubMed ID: 9436421 [Abstract] [Full Text] [Related]